Thomas Malley Insider Trading $OVAS Millendo Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Malley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Malley. Thomas Malley is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Cougar Biotechnology, Inc. ($CGRB) and Director in Kura Oncology, Inc. ($KURA) and Director in OvaScience, Inc. ($OVAS) and Director in BeiGene, Ltd. ($BGNE) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Thomas Malley in Millendo Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 204,981 shares
Current Value: $305,422
Latest Transaction: Jul 05 2017
$OVAS Market Capitalization: $55.19M
$OVAS Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas Malley in Millendo Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BGNE, CGRB, KNSA, KURA, OVAS, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 05 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 7,873 | 0 | 204,981 | 197.1 K to 205 K (+3.99 %) |
| Apr 04 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 7,085 | 0 | 197,108 | 190 K to 197.1 K (+3.73 %) |
| Jan 04 2017 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 1.53 | 8,660 | 13,250 | 190,023 | 181.4 K to 190 K (+4.77 %) |
| Oct 04 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,850 | 0 | 181,363 | 179.5 K to 181.4 K (+1.03 %) |
| Jul 05 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 2,543 | 0 | 179,513 | 177 K to 179.5 K (+1.44 %) |
| Jun 06 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Option Exercise | A | 7.38 | 12,000 | 88,560 | 12,000 | |
| Jun 03 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 7.00 | 50,000 | 350,000 | 176,970 | 127 K to 177 K (+39.38 %) |
| Apr 04 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,396 | 0 | 126,970 | 125.6 K to 127 K (+1.11 %) |
| Jan 05 2016 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,356 | 0 | 125,574 | 124.2 K to 125.6 K (+1.09 %) |
| Oct 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 0.00 | 1,560 | 0 | 124,218 | 122.7 K to 124.2 K (+1.27 %) |
| Jul 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 28.93 | 458 | 13,250 | 122,658 | 122.2 K to 122.7 K (+0.37 %) |
| Jun 08 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Option Exercise | A | 36.19 | 12,000 | 434,280 | 12,000 | |
| Apr 09 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Buy | P | 28.50 | 5,000 | 142,500 | 122,200 | 117.2 K to 122.2 K (+4.27 %) |
| Apr 02 2015 | OVAS | OvaScience, Inc. | Malley Thomas | Director | Grant | A | 34.73 | 381 | 13,232 | 117,200 | 116.8 K to 117.2 K (+0.33 %) |
Page: 1